ArticleInternational journal of molecular sciences2025

Targeting Heat Shock Transcription Factor 4 Enhances the Efficacy of Cabozantinib and Immune Checkpoint Inhibitors in Renal Cell Carcinoma.

Saeki Saito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.